摘要
本综述讨论了一些研究最多的具有生物或药用活性的钒(符号 V)配合物的生物形态,以强调 V 物种在生物介质中分布的重要性。血液或细胞中存在的化学物质的确切知识可以提供关于 V 潜在药物的生物学效应的基本信息。在血清中,钒可以与低分子(柠檬酸、乳酸盐、草酸盐、氨基酸等,用 bL 表示)和高分子量(转铁蛋白、白蛋白、免疫球蛋白等蛋白质)成分相互作用,而与红血细胞会干扰这些药物向靶细胞的转运。通过分析仪器和计算数据讨论了 bLs 和蛋白质的相互作用。还讨论了活性 V 物种的命运,当它们存在于真实的血清样品中以及它们到达并穿过细胞膜时。本综述中选择的 V 配合物的差异(供体原子、稳定性、配位几何、电荷、亲水性平衡、取代基和氧化还原特性)涵盖了与 bLs 和蛋白质相互作用的所有可能模式,允许研究化合物的生物分布来预测。这种方法可以应用于新合成的潜在 V 药物。
关键词: 钒药物、生物分子、生物配体、生物分布、血清蛋白、分子治疗。
Current Medicinal Chemistry
Title:Pharmacologically Active Vanadium Species: Distribution in Biological Media and Interaction with Molecular Targets
Volume: 28 Issue: 35
关键词: 钒药物、生物分子、生物配体、生物分布、血清蛋白、分子治疗。
摘要: Biospeciation of some of the most studied vanadium (symbol V) complexes with biological or medicinal activity is discussed in this review in order to emphasize the importance of the distribution of V species in biological media. The exact knowledge of the chemical species present in blood or cells may provide essential information regarding the biological effect of V potential drugs. In blood serum, vanadium species can interact with low (citrate, lactate, oxalate, amino acids, etc., indicated with bL) and high molecular mass (proteins like transferrin, albumin, immunoglobulins, etc.) components, while the interaction with red blood cells can interfere with the transport of these drugs towards the target cells. The interaction of bLs and proteins is discussed through the analysis of instrumental and computational data. The fate of the active V species, when these are in the real serum samples and when they reach and cross cell membranes, is also discussed. The differences in the V complexes selected in this review (donor atoms, stability, coordination geometry, electric charge, hydrolipophilicity balance, substituents and redox properties) cover all the possible modes of interaction with bLs and proteins, allowing for the biodistribution of the studied compounds to be predicted. This approach could be applied to newly synthesized potential V drugs.
Export Options
About this article
Cite this article as:
Pharmacologically Active Vanadium Species: Distribution in Biological Media and Interaction with Molecular Targets, Current Medicinal Chemistry 2021; 28 (35) . https://dx.doi.org/10.2174/0929867328666210531144021
DOI https://dx.doi.org/10.2174/0929867328666210531144021 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polymorphism in Endothelin-1 Gene: An Overview
Current Clinical Pharmacology Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
Mini-Reviews in Medicinal Chemistry Potassium Channels: Novel Emerging Biomarkers and Targets for Therapy in Cancer
Recent Patents on Anti-Cancer Drug Discovery Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies Phytosterols in Cancer: From Molecular Mechanisms to Preventive and Therapeutic Potentials
Current Medicinal Chemistry Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm
Current Gene Therapy Experimental Onco-Immunology Revisited
Current Cancer Therapy Reviews Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer
Current Cancer Drug Targets Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid
Current Drug Targets Physiologically Based Mathematical Models to Optimize Therapies Against Metastatic Colorectal Cancer: A Mini-Review
Current Pharmaceutical Design αvβ3 Integrin-Targeted Peptide/Peptidomimetic-Drug Conjugates: In-Depth Analysis of the Linker Technology
Current Topics in Medicinal Chemistry Review of Clinical Equipoise: Examples from Oncology Trials
Current Reviews in Clinical and Experimental Pharmacology Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives
Current Medicinal Chemistry The Role of Tumor Suppressor DLC-1: Far From Clear
Anti-Cancer Agents in Medicinal Chemistry 2-(ω-Carboxyethyl)pyrrole Antibody as a New Inhibitor of Tumor Angiogenesis and Growth
Anti-Cancer Agents in Medicinal Chemistry p53 Gene Family: Structural, Functional and Evolutionary Features
Current Genomics Developments in Synthesis of the Anti-inflammatory Drug, Celecoxib: A Review
Recent Patents on Inflammation & Allergy Drug Discovery Shutting Down the Furnace: Preferential Killing of Cancer Cells with Mitochondrial-Targeting Molecules
Current Medicinal Chemistry Heparanase Patents: Dim Past and Bright Future
Recent Patents on Inflammation & Allergy Drug Discovery Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism